hotspot -WSS

hotspot

author：hotspot 2025-10-02 23:45:33 - browse：6454

The sign of University of Texas MD Anderson Cancer Center in Houston, Texas in front of the Sheikh Zayed Building — coverage from STAT — Adobe

Early last year, MD Anderson Cancer Center leadership had a problem on their hands: a contentious dispute between one of its most powerful researchers and a junior scientist over authorship, credit, and charges of verbal abuse. High-ranking officials at the cancer center tried — and failed — to resolve the feud, and documents obtained by STAT shed new light on the deep divisions at the heart of this case.

The Texas cancer center outsourced assessing the conflict between early-career nephrologist Jamie Lin and leading oncologist Padmanee Sharma to the law firm Ropes & Gray. The firm investigated the authorship and scientific credit portions of the dispute and concluded that Sharma was likely responsible for a scientific hypothesis at the heart of the feud and should be named as a co-senior author on a key manuscript.

But a separate investigation, commissioned by Lin and conducted by a former official at the federal Office of Research Integrity, tells a somewhat different story. That review looked into plagiarism after Sharma claimed Lin had wrongly omitted the senior researcher as an author from a manuscript built on research to which Sharma contributed. But this second investigation found no evidence of plagiarism between two manuscripts submitted to the journals Cancer Immunology Research and Journal of Clinical Investigation Insight.

Lin provided STAT with copies of an executive summary of the Ropes & Gray investigation as well as the conclusions of the plagiarism investigation. These documents are alluded to in legal filings but have not been previously reported. Lin has filed a lawsuit against Sharma in the Harris County District Court alleging retaliation, harassment, threatening, and intellectual theft by Sharma; she’s also asking for $5 million in damages.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Novavax promises a turnaround & Lilly roils the obesity market
Next article： Free speech concerns arise in wake of journal editor Eisen's firing

WSS

The Sacklers, horror, and ‘The Fall of the House of Usher’

Abortion policy in the spotlight at Republican debate

Trans patients at the end of life deserve respect and dignity

Vivek Ramaswamy made waves in the debate, much as in biotech

Study: New antibiotic targets gonorrhea as well as last existing drug

Sanofi CEO defends move to abandon profit guidance, boost research

explore

hotspot

entertainment

How to save PrEP access — and even expand it

Health officials lay out plans to cope with respiratory virus season

Medical leaders decry Supreme Court decision on affirmative action

Victims of gun violence feel impacts long after bullet wound

Sports medicine is finally prioritizing gender equality

MoonLake credibility takes another hit with mid

Jerome Adams on the need for new antivirals for Covid

What past blockbusters can tell us about future of Wegovy and other weight loss medicines

Affirmative action in medical school literally saved lives

Biotech incubator Curie.Bio graduates its first startup

hotspot

10 million people disenrolled from Medicaid over past six months

Diversify hospital leadership teams to protect BIPOC patient health

Removing probiotics from the NICU could threaten preemies' health

Ambulance rides for just $100? Advisers want major billing fixes

Wegovy improves function in certain heart failure patients

DeSantis wants to import drugs. Biden’s FDA blasted his plan

focus

hotspot

focus

knowledge